ICBMT 2026

HOME

Program at a Glance

  • : Broadcasted to Room B

  • : AI English Subtitles Service

  • Kor

    : Session in Korean

  • : Mobile Voting Available

Day 1: Sep. 17 (Thu)

Room A (1F) Room B (1F) Room C (2F) Room D (2F)
09:00-10:00 Oral Presentation 1 Oral Presentation 2 Oral Presentation 3 Oral Presentation 4
10:00-10:10 Break
10:10-10:30 Opening Ceremony
10:30-11:50 Plenary Session 1
CAR T Cell Therapy
11:50-12:00 Break
12:00-12:40 Luncheon Symposium 1 Luncheon Symposium 2 Luncheon Symposium 3
12:40-13:00 Break
13:00-14:20 Plenary Session 2
GVHD
14:20-14:30 Break
14:30-16:00 Joint Symposium 1
(ASTCT-KSBMT)		 Scientific Session 1 Scientific Session 2 Education Session 1
Evolving T-Cell Manipulation Strategies: Optimization of PTCy and New Frontiers in T-Cell Depletion Next-Generation Immune Effector Cell Therapies: Emerging Platforms and Biological Insights Advances in Immunotherapy and Transplant Strategies in Pediatric Hematologic Malignancies Additional Cellular Support after Allogeneic Transplantation
16:00-16:10 Break
16:10-16:40 Poster
Exhibition Hall (3F)
16:40-16:50 Break
16:50-18:20 Joint Symposium 2
(EBMT-KSBMT)		 Scientific Session 3 Scientific Session 4
Evolving Donor Issues in Allogeneic HSCT: From HLA Matching to Germline Screening and Emerging Concerns Post-Transplant Residual Disease in Acute Leukemia: Monitoring and Therapeutic Strategies Science Behind Treatment Response and Relapse
18:20-18:30 Break
18:40~ Welcome Reception

Day 2: Sep. 18 (Fri)

Room A (1F) Room B (1F) Room C (2F) Room D (2F)
08:30-09:00 Satellite Symposium 1 Satellite Symposium 2
09:00-10:00 Oral Presentation 5 Oral Presentation 6 Oral Presentation 7 Oral Presentation 8
10:00-10:10 Break
10:10-11:40 Joint Symposium 3
(East Asia Collaborative Session)		 Scientific Session 5 Scientific Session 6 Education Session 2
The CAR-T Landscape in East Asia: Approvals, Coverage, Domestic Development, and Regulatory Frameworks for Cell Therapy AML/MDS Biology Potential Role of AI in Hematology and Cellular Therapy Toxicities of Transplant and Immunotherapy
11:40-11:50 Break
11:50-12:00 Break
12:00-12:40 Luncheon Symposium 4 Luncheon Symposium 5 Luncheon Symposium 6
12:40-13:00 Break
13:00-14:30 Joint Symposium 4
(ISCT-KSBMT)		 Scientific Session 7 Nursing Session 1

Kor

Education Session 3
Next-Generation Immune Cell Therapies Beyond CAR-T Expanding CAR T-Cell Therapy beyond Lymphoid Malignancies: Myeloid Neoplasms, Solid Tumors, and Autoimmune Diseases Multidisciplinary Approach to Hematopoietic Stem Cell Transplantation Patients I Practical Issues in Stem Cell Transplantation 2026
14:30-14:40 Break
14:40-15:20 Presidential Symposium
Lymphoma Cell Therapy
15:20-16:00 Plenary Session 3
HSCT for Non-Malignant Disease
16:00-16:10 Break
16:10-16:40 Poster
Exhibition Hall (3F)
16:40-16:50 Break
16:50-18:20 Debate Session

Kor

Joint Symposium 5
(JSTCT-KSBMT)		 Scientific Session 8
[DS01] Allogeneic HSCT in Patients with AML or MDS with TP53 Alternation
[DS02] HSCT for HLH: Decreased Conditioning Intensity vs. Increased Conditioning Intensity		 EBV-Associated Diseases and HSCT: From CAEBV to Post-Transplant Complications Advances in HSCT Conditioning
18:20-18:30
18:45~ Gala Dinner

Day 3: Sep. 19 (Sat)

Room A (1F) Room B (1F) Room C (2F) Room D (2F)
07:00-08:30 KSBMT Business Meeting
08:30-09:00 Satellite Symposium 3
09:00-10:00 Joint Symposium 6
(TSBMT-KSBMT)		 Oral Presentation 9 Oral Presentation 10
Endothelial Injury after HSCT: Cutting-Edge Science and Real-World Practice in Türkiye and Korea
10:00-10:10 Break Break
10:10-11:10 Scientific Session 9 Scientific Session 10 Nursing Session 2

Kor
11:10-11:40 Insights on GVHD Prediction, Prevention and Management Immune Effector Cell Therapy in Lymphoid Malignancies: From Pivotal Trials to Real-World Practice Break
11:40-12:20 Break Break
12:20-12:30 Closing Ceremony
12:30-13:00 KSBMT General Assembly